Efficacy of monoclonal antibody anti CD20 in extranodal minimal residual disease eradication

被引：0
|
作者：
Petrilli, M. P.
Cinieri, S.
Giordano, G.
Ruggiero, T.
Cavotta, S.
Capussela, E.
Ferrandina, C.
Gasbarrino, C.
Fraticelli, V.
Monaco, M.
Storti, S.
机构：
[1] Univ Cattolica Sacro Cuore, Ctr Ric & Formaz Alta Tecnol Sci Biomed, Unit Operat Oncoematol, Sede Campobasso, Italy
[2] Univ OORR, UO Ematol Azienda Mista Osped, Foggia, Italy
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：60 / 60
页数：1
相关论文
共 50 条
  • [1] Rituxan™:: Anti CD20 monoclonal antibody for the treatment of lymphoma.
    Grillo-López, AJ
    White, CA
    Dallaire, BK
    Varns, C
    Shen, D
    McClure, A
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 746 - 746
  • [2] Anti-CD20 monoclonal antibody (Mabthera®) administration post chlorambucil in mantle cell lymphoma (MCL) patients leads to eradication of minimal residual disease.
    Dimopoulou, MN
    Siakantaris, MP
    Kontopidou, FN
    Angelopoulou, MK
    Doussis-Anagnostopoulou, IA
    Korkolopoulou, P
    Kittas, C
    Pangalis, GA
    BLOOD, 2000, 96 (11) : 236B - 236B
  • [3] Complement deficiencies limit CD20 monoclonal antibody treatment efficacy in CLL
    O Middleton
    E Cosimo
    E Dobbin
    A M McCaig
    C Clarke
    A M Brant
    M T Leach
    A M Michie
    H Wheadon
    Leukemia, 2015, 29 : 107 - 114
  • [4] Complement deficiencies limit CD20 monoclonal antibody treatment efficacy in CLL
    Middleton, O.
    Cosimo, E.
    Dobbin, E.
    McCaig, A. M.
    Clarke, C.
    Brant, A. M.
    Leach, M. T.
    Michie, A. M.
    Wheadon, H.
    LEUKEMIA, 2015, 29 (01) : 107 - 114
  • [5] Production and Characterization of New Anti-Human CD20 Monoclonal Antibody
    Fasihi-Ramandi, Mahdi
    Amani, Jafar
    Salmanian, Ali-Hatef
    Moazzeni, Seyed Mohammad
    Ahmadi, Kazem
    IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2015, 14 (05) : 502 - 508
  • [6] Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab
    Rouge, Lionel
    Chiang, Nancy
    Steffek, Micah
    Kugel, Christine
    Croll, Tristan I.
    Tam, Christine
    Estevez, Alberto
    Arthur, Christopher P.
    Koth, Christopher M.
    Ciferri, Claudio
    Kraft, Edward
    Payandeh, Jian
    Nakamura, Gerald
    Koerber, James T.
    Rohou, Alexis
    SCIENCE, 2020, 367 (6483) : 1224 - +
  • [7] INFLUENCE OF HISTONE DEACETYLASE INHIBITORS (HDACI) ON CD20 EXPRESSION AND EFFICACY OF ANTI-CD20 MONOCLONAL ANTIBODIES
    Wanczyk, M.
    Kozikowski, M.
    Dwojak, M.
    Bojarczuk, K.
    Winiarska, M.
    HAEMATOLOGICA, 2013, 98 : 409 - 409
  • [8] Measuring CD20 binding for humanization of anti-CD20 antibody
    Meng, YJG
    Hong, K
    Presta, L
    Penn, A
    Adams, C
    Chuntharapai, A
    Yang, JH
    Lu, YM
    Wong, WL
    FASEB JOURNAL, 2004, 18 (04): : A59 - A59
  • [9] Development of a novel anti-canine CD20 monoclonal antibody with diagnostic and therapeutic potential
    Ito, Daisuke
    Brewer, Susan
    Modiano, Jaime F.
    Beall, Melissa J.
    LEUKEMIA & LYMPHOMA, 2015, 56 (01) : 219 - 225
  • [10] Loss of CD20 expression following treatment with anti-CD20 monoclonal antibody in chronic lymphocytic leukemia.
    Savage, KJ
    Weng, AP
    Kutok, JL
    Pinkus, G
    Gribben, JG
    BLOOD, 2002, 100 (11) : 364B - 364B
12345